18 completed, 3 unknown, 2 recruiting, 2 terminated. 26 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 26 | Completed 18, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 1 |
| Phase 2 | 5 | Completed 3, Unknown 2 |
Follow Hemodialysis: new trials by email Literature Review of Hemodialysis trials Research Report on Hemodialysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Effect of Manuka Honey Oral Rinse in Periodontitis Patients Undergoing Hemodialysis Manuka honey oral rinse., Normal saline rinses. - Periodontitis, Hemodialysis | Phase 3 | Recruiting | Ain Shams University | 150 | 2024-10-01 | 2025-12-31 |
| Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction Lidocaine Spray: Each ml contained 10 mg lidocaine and ethanol. Applied to the local site to provide anesthesia, Benzocaine spray, Placebo group (control arm) - Pain, Satisfaction | Phase 3 | Completed | TC Erciyes University | 60 | 2024-04-01 | 2025-12-01 |
| Effects of Low Protein Diet Supplemented With Ketoanalogues on Preservation of Kidney Function in Incremental Dialysis Ketosteril - Kidney Function, Hemodialysis | Phase 2 / Phase 3 | Unknown | Chulalongkorn University | 50 | 2021-12-01 | 2021-09-01 |
| Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure Human Erythropoiesis Injection (CHO cell), Recombinant Erythropoiesis Stimulating Protein Injection(CHO cell) - Kidney Failure, Chronic, Hemodialysis | Phase 3 | Unknown | Shenyang Sunshine Pharmaceutical Co., LTD. | 300 | 2021-07-01 | 2022-01-27 |
| Ramipril in Pediatric Patients on Hemodialysis Ramipril, placebo - Hemodialysis | Phase 2 / Phase 3 | Completed | Ain Shams University | 135 | 2018-12-01 | 2020-10-14 |
| A Web Application for Improving Communication on Hemodialysis Rounds Web-App, Paper - Hemodialysis | Phase 3 | Completed | University of Alberta | 77 | 2018-11-28 | 2020-03-25 |
| Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) Cannabis oil, Placebo/ Regular Oil - Protein-Energy Malnutrition, Hemodialysis | Phase 3 | Withdrawn | Assaf-Harofeh Medical Center | 2018-09-15 | 2021-07-28 | |
| Alirocumab in Patients on a Stable Dialysis Regimen Alirocumab 150 MG/ML [Praluent] - Hemodialysis, Peritoneal Dialysis | Phase 3 | Recruiting | Baylor Research Institute | 20 | 2018-05-01 | 2020-02-12 |
| Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Human Acellular Vessel (HAV), Arteriovenous fistula (AVF), Hemodialysis - Renal Failure, End Stage Renal Disease | Phase 3 | Completed | Humacyte, Inc. | 242 | 2017-09-29 | 2025-11-20 |
| Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis Human Acellular Vessel (HAV), ePTFE graft - Renal Failure, End Stage Renal Disease | Phase 3 | Completed | Humacyte, Inc. | 355 | 2016-05-24 | 2026-08-19 |
| A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia PA21 - Hemodialysis, Hyperphosphatemia | Phase 3 | Completed | Kissei Pharmaceutical Co., Ltd. | 35 | 2013-04-29 | 2018-10-09 |
| A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia PA21, Sevelamer hydrochloride - Hemodialysis, Hyperphosphatemia | Phase 3 | Completed | Kissei Pharmaceutical Co., Ltd. | 213 | 2013-04-23 | 2018-10-09 |
| Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study Lanthanum Carbonate, Calcium Carbonate - Hemodialysis, Hyperphosphatemia | Phase 3 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2309 | 2011-12-24 | 2020-11-30 |
| Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients Lowering the dialysate sodium - Hemodialysis | Phase 3 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 35 | 2011-11-01 | 2017-11-06 |
| Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism paricalcitol, maxacalcitol, paricalcitol placebo - Secondary Hyperparathyroidism, Hemodialysis | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 255 | 2011-05-01 | 2013-06-06 |
| Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis Prasugrel, Clopidogrel - Hemodialysis, Chronic Renal Failure | Phase 3 | Completed | University of Patras | 70 | 2010-05-01 | 2010-11-16 |
| Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients nicotinamide, sevelamer, cinacalcet - Chronic Renal Failure, Hemodialysis | Phase 3 | Terminated | Centre Hospitalier Universitaire, Amiens | 176 | 2010-01-01 | 2016-05-16 |
| HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit Standard Hemodialysis, with Blood Volume Management (BVM®) only, with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring - Hemodialysis | Phase 2 / Phase 3 | Completed | University Hospital, Caen | 600 | 2008-12-01 | 2010-03-03 |
| GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface, Percutaneous Transluminal Angioplasty - Renal Failure, Hemodialysis | Phase 3 | Completed | W.L.Gore & Associates | 293 | 2008-09-01 | 2014-10-21 |
| The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis Patients Pomegranate juice, Placebo - End Stage Renal Disease, Hemodialysis | Phase 3 | Completed | Western Galilee Hospital-Nahariya | 2008-07-01 | 2010-03-23 |
Showing 20 of 26. Sign in to see all of them.
Kidney Failure, Chronic (10) · Hyperphosphatemia (3) · Renal Insufficiency (3) · Hypertension (2) · Hypotension (2) · Vascular Calcification (2) · Acute Kidney Injury (1) · Arteriovenous Fistula (1) · Chronic Kidney Disease-Mineral and Bone Disorder (1) · Dyslipidemias (1) · Edema (1) · Feeding and Eating Disorders (1) · Hypercholesterolemia (1) · Hyperparathyroidism, Secondary (1) · Hypertrophy, Left Ventricular (1)
Pathological Conditions, Signs and Symptoms (14) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Kidney Diseases (13) · Male Urogenital Diseases (13) · Urogenital Diseases (13) · Urologic Diseases (13) · Pathologic Processes (12) · Chronic Disease (11) · Disease Attributes (11) · Renal Insufficiency, Chronic (10) · Renal Insufficiency (9) · Nutritional and Metabolic Diseases (6) · Cardiovascular Diseases (5) · Metabolic Diseases (5)
Sevelamer (2) · Angioplasty (1) · Arteriovenous Shunt, Surgical (1) · Atenolol (1) · Calcium Carbonate (1) · Cinacalcet (1) · Citric Acid (1) · Clopidogrel (1) · Dalteparin (1) · Diet, Protein-Restricted (1) · Heparin (1) · Lidocaine (1) · Lisinopril (1) · Melatonin (1) · Niacinamide (1)
Ain Shams University (2) · Humacyte, Inc. (2) · Kissei Pharmaceutical Co., Ltd. (2) · Western Galilee Hospital-Nahariya (2) · AbbVie (prior sponsor, Abbott) (1) · Assaf-Harofeh Medical Center (1) · Baylor Research Institute (1) · Centre Hospitalier Universitaire, Amiens (1) · Chulalongkorn University (1) · Indiana University (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Meander Medical Center (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Ottawa Hospital Research Institute (1) · Shenyang Sunshine Pharmaceutical Co., LTD. (1)
United States (6) · Canada (4) · Israel (4) · Japan (4) · Egypt (2) · France (2) · China (1) · Germany (1) · Greece (1) · Netherlands (1) · Poland (1) · Portugal (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Shamik Parikh, MD (2) · Alan S. Kliger, M.D. (1) · Cara East, MD (1) · Francois Madore, MD (1) · Gerald J. Beck, Ph.D. (1) · Kazuya Kobayashi, BA (1) · Marc Rodger, MD, MSc (1) · Michael V. Rocco, M.D. (1) · Paul W. Eggers, Ph.D. (1) · Piet ter Wee, MD, PhD (1) · Rajiv Agarwal, MD (1) · Rita Suri, MD, MSc (1)
PMID 40576086, PMID 37651553, PMID 39498822, PMID 16034009, PMID 17167114, PMID 19076157, PMID 19332456, PMID 19339093, PMID 20082919, PMID 21307840, PMID 21493741, PMID 21663949, PMID 21775973, PMID 22422538, PMID 22461539, PMID 22535635, PMID 23149295, PMID 23332990, PMID 23970131, PMID 24072417, PMID 24398888, PMID 24593225, PMID 25019001, PMID 26444323, PMID 26924051, PMID 27774730, PMID 28094031, PMID 28301073, PMID 29621747, PMID 30717951, PMID 31826326, PMID 34003226, PMID 34377501, PMID 35224730, PMID 35686561, PMID 35801187, PMID 37662589, PMID 38189593, PMID 42556897, PMID 42613284
2015 (1), R01DK062030 (1), U01DK066597 (1)